Orion Corporation converts 337,000 A shares into B shares.

Orion Corporation has converted 337,000 A shares into 337,000 B shares, increasing the total number of shares to 141,134,278. The number of A shares is now 31,971,783, and the number of B shares is 109,162,495. The total number of votes has increased to 748,598,155. This conversion was made in accordance with Orion's Articles of Association.

Orion Corporation has announced a significant change in its share structure, converting 337,000 A shares into B shares. This conversion, executed in accordance with the company's Articles of Association, has been entered into the Trade Register on August 20, 2025 [1].

The total number of shares in Orion Corporation has increased to 141,134,278, comprising 31,971,783 A shares and 109,162,495 B shares. The total number of votes has also increased to 748,598,155 following the conversion [1].

Orion Corporation, a globally operating Nordic pharmaceutical company, has a portfolio that includes proprietary and generic medicines, as well as consumer health products. The company's core therapy areas are oncology and pain, with products used to treat cancer, neurological diseases, and respiratory conditions. In 2024, Orion's net sales amounted to EUR 1,542 million, with approximately 3,700 professionals employed worldwide [1].

The conversion of shares aligns with Orion's strategic goals and is aimed at optimizing its share structure and capitalization. The company's A and B shares are listed on Nasdaq Helsinki.

References:
[1] https://finance.yahoo.com/news/337-000-orion-corporation-shares-060000092.html